AdreView Prices, Coupons and Patient Assistance Programs
AdreView (iobenguane I 123) is a member of the diagnostic radiopharmaceuticals drug class and is commonly used for Diagnosis and Investigation.
This AdreView price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for AdreView intravenous solution (370 mBq/5 mL) is around $4,118 for a supply of 5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
AdreView is available as a brand name drug only, a generic version is not yet available. For more information, read about generic AdreView availability.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
AdreView Coupons and Rebates
AdreView offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for AdreView
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about AdreView (iobenguane I 123)
- Side Effects
- Dosage Information
- Drug Interactions
- En Español
- Drug class: diagnostic radiopharmaceuticals
- FDA Approval History